Autism Spectrum Disorder Trial, Recruiting (NCT07081724)

Autism Spectrum Disorder Trial, Recruiting NCT07081724 Sponsor: Drexel University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07081724 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your child is between 16 and 48 months old (roughly 1 year 4 months to 4 years old)
You, as the parent or guardian, are willing to give consent for your child to take part
Your child is currently on a waiting list to be formally assessed for autism
The parent or guardian taking part speaks English
Your child scored 8 or higher on the initial autism screening questionnaire (M-CHAT-R/F), or 2 or higher on the follow-up version, suggesting some likelihood of autism

Who may not be able to join:

Your child has already received an official autism diagnosis
Your child is currently receiving more than 5 hours per week of autism-specific therapy or early intervention programs
Your child was born significantly premature (before 36 weeks) and weighed less than 2,500 grams (about 5.5 pounds) at birth
Your child is not yet walking, has uncorrected serious hearing or vision problems, or has a known neurological condition or genetic condition (such as Down syndrome)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07081724

Sponsor: Drexel University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

More information: https://clinicaltrials.gov/study/NCT07081724

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your child is between 16 and 48 months old (roughly 1 year 4 months to 4 years old)
You, as the parent or guardian, are willing to give consent for your child to take part
Your child is currently on a waiting list to be formally assessed for autism
The parent or guardian taking part speaks English
Your child scored 8 or higher on the initial autism screening questionnaire (M-CHAT-R/F), or 2 or higher on the follow-up version, suggesting some likelihood of autism

Who may not be able to join:

Your child has already received an official autism diagnosis
Your child is currently receiving more than 5 hours per week of autism-specific therapy or early intervention programs
Your child was born significantly premature (before 36 weeks) and weighed less than 2,500 grams (about 5.5 pounds) at birth
Your child is not yet walking, has uncorrected serious hearing or vision problems, or has a known neurological condition or genetic condition (such as Down syndrome)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Drexel University

Registry

ClinicalTrials.gov

Start date

25 August 2025

Est. completion

1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Goal Attainment Scaling

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov